Dangling the carrot---I wish he would walk the talk
What was
Turning to commercial business development. As we move further along our journey as a bottom line focused by a pharma company, I know there is a great deal of anticipation for further details around product acquisitions and future growth. I want to reiterate that our growth trajectory for both the top and bottom line has put us in a position of strength. This should facilitate the acquisition of new assets, which could be instruments of value creation for shareholders.
With M&A more important than ever for Theratechnologies, the timing is ideal to welcome two new Board members, Jordan Zwick and Elina Tea, both with an abundance of expertise and experience in this area.
THE NEED FOR EXPERTISE IN M&A IS A DIRECT CONSEQUENCE OF NOT BEING ABLE TO EXECUTE AND RECOGNIZE PROBLEMS BEFORE FACING A BRICK WALL